Alzheimer Dementia (AD) Recruiting Phase 4 Trials for Methylphenidate (DB00422)

Also known as: Alzheimer's Dementia / Alzheimer Dementia

IndicationStatusPhase
DBCOND0078271 (Alzheimer Dementia (AD))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03811847A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.Supportive Care